Mountain View, CA, United States of America

Rekha R Nair

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rekha R Nair: Innovator in Stem Cell Differentiation

Introduction

Rekha R Nair is a prominent inventor based in Mountain View, CA (US). She has made significant contributions to the field of stem cell research, particularly in the differentiation of pluripotent stem cells. Her innovative methods have the potential to advance therapeutic applications in regenerative medicine.

Latest Patents

Rekha R Nair holds a patent titled "Methods for differentiating pluripotent stem cells in dynamic suspension culture." This patent describes methods for differentiating pluripotent stem cells to neuroectoderm using small molecule or protein inhibitors of TGFβ/Activin/Nodal signaling and BMP signaling. The patent outlines protocols for differentiating human embryonic stem cells first to neuroectoderm, then to glial progenitor cells, and further to oligodendrocyte progenitor cells (OPCs). The methods disclosed in the patent reproducibly produce neuroectoderm progenitor cells by day 7, glial progenitor cells by day 21, and OPCs by day 42 of the differentiation process. Rekha R Nair has 1 patent to her name.

Career Highlights

Rekha R Nair is currently associated with Lineage Cell Therapeutics, Inc., where she continues her research in stem cell differentiation. Her work is pivotal in exploring new avenues for cell-based therapies.

Collaborations

Rekha collaborates with talented individuals in her field, including Stephanie Kayser and Abhirath S Parikh. These collaborations enhance the research and development of innovative solutions in stem cell technology.

Conclusion

Rekha R Nair is a trailblazer in the field of stem cell research, with her patented methods paving the way for advancements in regenerative medicine. Her contributions are invaluable to the scientific community and hold promise for future therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…